# PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis

> **NCT04000906** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Geneva** · enrollment: 18 (actual)

## Conditions studied

- Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Nab paclitaxel
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT04000906
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-11
- **Primary completion:** 2023-12-12
- **Final completion:** 2024-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04000906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04000906, "PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04000906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*